)
Visual
test
Crescent Biopharma
Crescent Biopharma (CBIO) investor relations material
Crescent Biopharma Partnership summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Partnership summary4 Dec, 2025
Opening remarks and agenda
Conference call and webcast held to announce a transformational partnership with Kelun-Biotech and provide pipeline updates, with leadership team introduced.
Forward-looking statements and safe harbor provisions noted.
Objectives of the partnership
Partnership aims to accelerate and expand leadership in immuno-oncology (IO) and ADC combination therapies, advancing next-generation solid tumor therapeutics.
Collaboration enables parallel clinical data generation in the US, Europe, and Greater China.
Both parties will co-develop CR-001 and CR-003 (SKB105), focusing on global and regional clinical advancement.
Partner introductions and roles
Crescent advances CR-001 in the US and Europe, while Kelun-Biotech leads in Greater China.
Kelun-Biotech brings end-to-end ADC development capabilities and access to Chinese markets.
Both companies share clinical data and can independently develop CR-001 in additional combinations.
Impact of CR-001 China rights grant on Crescent?
Elaborate on CR-001's combination synergy mechanism.
Which milestones does financing support into 2028?
CR001's manufacturing advantages over Ivonescimab?
Synergy rationale for CR001 with PD-L1/IB6 ADCs?
How does CR001's Phase 1 design de-risk development?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 5 FebFSC1V
2025 revenue stable, AI and partnerships drive growth, 2026 outlook positive. - 5 FebIDCC
Record ARR, net income, and EBITDA in 2025; 2026 outlook remains strong. - 5 FebKGS
$675M acquisition expands distributed power reach and digital infrastructure growth, accretive to earnings. - 5 FebLADR
Q4 2025 distributable earnings hit $21.4M, with investment grade ratings and strong capital metrics. - 5 FebMCFT
Q2 FY26 sales and margins surged, with guidance raised and a key acquisition announced. - 5 FebBERGEPAINT
Q3 FY26 delivered strong volume growth and record margins, but net profit declined. - 5 FebMDU
2025 net income was $190.4M, with growth in gas and pipeline segments and 2026 EPS guidance at $0.93–$1.00. - 5 FebSCSC
Quarterly net sales up 2.5% to $766.5M; margin pressure and guidance lowered. - 5 FebSOBI
16% revenue growth and 40% margin driven by strategic launches and pipeline progress. - 5 Feb524742
Double-digit growth, strong margins, and major expansion in US and Latin America.
Next Crescent Biopharma earnings date
Q4 202519 Feb, 2026
Crescent Biopharma
Next Crescent Biopharma earnings date
Q4 202519 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage